Related Experiment Video
Updated: Aug 20, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Transfusions and early outcomes in anaemic patients undergoing off- or on-pump coronary artery bypass grafting
Andreas Koster1, Armin Zittermann2, Jan F Gummert2
1Institute for Anesthesiology and Pain Therapy, Herz- und Diabeteszentrum NRW, Ruhr-University, Bochum, Germany.
Insights
Off-pump coronary artery bypass grafting (OPCAB) reduces transfusions and renal replacement therapy needs compared to on-pump coronary artery bypass grafting (ONCAB) in anemic patients. However, OPCAB increases wound infection risk, with similar mortality rates for both procedures.
Area of Science:
- Cardiovascular Surgery
- Anesthesiology
- Critical Care Medicine
Background:
- Preoperative anemia is common in patients undergoing coronary artery bypass grafting (CABG).
- Both off-pump coronary artery bypass grafting (OPCAB) and on-pump coronary artery bypass grafting (ONCAB) are surgical options for CABG.
- The choice between OPCAB and ONCAB may influence transfusion requirements and early outcomes, particularly in anemic patients.
Purpose of the Study:
- To compare transfusion rates and early outcomes between OPCAB and ONCAB in patients with preoperative anemia.
- To evaluate the impact of surgical approach on morbidity and mortality in this patient population.
Main Methods:
- Retrospective comparison of 1621 consecutive patients with preoperative anemia undergoing OPCAB or ONCAB.
- Propensity score analysis with inverse probability of treatment weighting was used.
- Endpoints included transfusion rates, early morbidity (e.g., renal replacement therapy, wound infection, stroke), and mortality (30-day and 1-year).
Main Results:
- OPCAB was associated with significantly fewer transfusions and a lower risk of postoperative renal replacement therapy compared to ONCAB.
- Patients undergoing OPCAB had a higher risk of wound infections than those undergoing ONCAB.
- There were no significant differences in perioperative stroke risk or 30-day and 1-year mortality between the OPCAB and ONCAB groups.
Conclusions:
- Both OPCAB and ONCAB are feasible surgical approaches for patients with preoperative anemia, demonstrating similar early morbidity and mortality.
- OPCAB offers benefits in reduced transfusion needs and lower risk of renal replacement therapy, but carries an increased risk of wound infections.
- The choice of surgical technique should consider the trade-offs between transfusion avoidance, renal protection, and infection risk.
Abstract:
We retrospectively compared transfusion rates and early outcomes in 1621 consecutive patients with preoperative anaemia undergoing off-pump coronary artery bypass grafting (OPCAB) or on-pump coronary artery bypass grafting (ONCAB) surgery using a propensity score analysis with inverse probability of treatment weighting. Endpoints were transfusions, early morbidity, and mortality. Surgeries were performed by 45 dedicated OPCAB and/or ONCAB surgeons during the 10-year study period. Operative data did not differ significantly between study groups with the exception of a more frequent use of bilateral internal mammary artery revascularization approach in OPCAB patients than ONCAB patients. OPCAB was associated with fewer transfusions and lower risk for the need of postoperative renal replacement therapy, but higher risk of wound infections than ONCAB. Perioperative stroke risk and 30-day and 1-year mortality did not differ significantly between the groups. Our data in a 'real-world setting' indicate that in patients with preoperative anaemia both ONCAB and OPCAB are feasible surgical approaches regarding early morbidity and mortality.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

